News
Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk o ...
Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, ...
6d
HealthDay on MSNAdults Diagnosed With Type 1 Diabetes Face Heart Health Issues, Risk Of Early DeathKey Takeaways People who develop type 1 diabetes in adulthood have a higher risk of heart disease and death from any ...
Cardiovascular medicine continues to grapple with the complexities of chronic heart failure (CHF), a condition predominantly ...
A new study puts the spotlight on the rising burden of ischemic heart disease across Southeast Asia, East Asia and Oceania, and calls for localized, equity-focused interventions in these regions. The ...
A new study puts the spotlight on the rising burden of ischemic heart disease across Southeast Asia, East Asia and Oceania, and calls for localized, equity-focused interventions in these regions.
Rapidly rising rates of heart disease across Southeast Asia, East Asia and Oceania are being driven by localized consequences ...
The bond between Kiribati — population 120,000 — and its near neighbor New Zealand, a country of 5 million people, might not appear the South Pacific’s most significant. But the acrimony ...
Many of the credit card offers that appear on the website are from credit card companies from which ThePointsGuy.com receives compensation. This compensation may impact how and where products appear ...
Leading life and health insurer AIA NZ today released its second latest Claims Compass, reporting $829.6M in total claims paid for the year ended 31 December 2024 – a $95M increase on the previous ...
has released the Aotearoa New Zealand Guidelines for the Prevention, Diagnosis, and Management of Acute Rheumatic Fever and Rheumatic Heart Disease 2024, marking a major step forward in our national ...
For nearly 60 years, checking cholesterol levels in a person’s blood has been the main way doctors identify who might be at risk of heart disease. But a new study from researchers at Chalmers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results